• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    India Intravenous Solution Market

    ID: MRFR/HC/43040-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    India Intravenous Solution Market Research Report By Nutrition Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml), Small Volume Bags (250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins Minerals, Parenteral Lipid Emulsion) and By End User (Hospital Clinics, Ambulatory Surgical Centers, Home Care)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Intravenous Solution Market Infographic
    Purchase Options

    India Intravenous Solution Market Summary

    The India Intravenous Solution market is projected to grow from 1500 USD Million in 2024 to 3500 USD Million by 2035.

    Key Market Trends & Highlights

    India Intravenous Solution Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 8.01% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3500 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 1500 USD Million, reflecting a strong foundation for future expansion.
    • Growing adoption of intravenous therapies due to increasing healthcare needs is a major market driver.

    Market Size & Forecast

    2024 Market Size 1500 (USD Million)
    2035 Market Size 3500 (USD Million)
    CAGR (2025 - 2035) 8.01%

    Major Players

    Reliance Industries Limited (IN), Tata Consultancy Services (IN), HDFC Bank Limited (IN), Infosys Limited (IN), ICICI Bank Limited (IN), Hindustan Unilever Limited (IN), State Bank of India (IN), Bharti Airtel Limited (IN), Wipro Limited (IN)

    India Intravenous Solution Market Trends

    Numerous important market factors are causing the India intravenous solution market to undergo substantial changes. In India, the need for intravenous solutions is being driven by the growing number of elderly people and the prevalence of chronic illnesses. The rise of this industry is also aided by improvements in medical technology and the expansion of the healthcare infrastructure. These solutions are becoming more and more necessary as a result of rising awareness of hydration therapy and the significance of intravenous treatments in critical care settings.

    Pre-packaged intravenous fluids and ready-to-use IV solutions are two examples of novel goods that might be developed to explore market opportunities. 

    As the government prioritizes expanding access to healthcare, businesses may reach underprivileged areas, strengthening distribution systems to satisfy the growing need. The Indian government's continuous efforts to increase healthcare facilities and lessen the strain on hospitals demonstrate the promise of intravenous solutions in home healthcare settings as well. Recent patterns show a move toward local production of generic intravenous solutions, which is being fueled by the government's emphasis on Make in India programs. Encouragement of local manufacturing not only lessens reliance on imported solutions but also increases the affordability and accessibility of intravenous treatment in a variety of healthcare settings.

    Additionally, the emergence of home care and telemedicine services in recent years has opened up new development opportunities by putting more of a focus on intravenous treatments administered outside of hospitals. Thus, driven by both rising technology and critical healthcare demands, the India Intravenous Solution Market is poised for major change.

    Market Segment Insights

    Intravenous Solution Market Nutrition Type Insights

    The India Intravenous Solution Market is witnessing notable growth, particularly within the Nutrition Type segment, which encompasses Total Parenteral Nutrition and Peripheral Parenteral Nutrition. Total Parenteral Nutrition plays a crucial role in providing essential nutrients to patients who are unable to ingest food orally, making it a vital component within clinical settings; the growing prevalence of chronic illnesses and increased surgical procedures in the country underline its significance in therapeutic care.

    In contrast, Peripheral Parenteral Nutrition caters to patients requiring less intensive nutritional support and serves an essential function during outpatient treatments, particularly in cases where full enteral feeding is not feasible.

    The convergence of advanced technologies and increasing demand from healthcare providers for tailored nutrition solutions propels the uptake of intravenous nutrition. Moreover, government initiatives aimed at improving healthcare infrastructure in India further bolster this market segment, as they facilitate the introduction and distribution of intravenous nutritional products. Challenges such as the need for skilled personnel to administer these solutions and the rising costs associated with high-quality parenteral nutrition are factors that stakeholders need to address.

    Overall, the Nutrition Type category within the India Intravenous Solution Market exemplifies a robust pathway for growth, driven by shifting healthcare needs and the critical nature of providing adequate nutritional support for patients undergoing medical treatments.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Intravenous Solution Market Bag Type Insights

    The Bag Type segment of the India Intravenous Solution Market is comprised primarily of Large Volume Bags and Small Volume Bags, each serving critical roles in medical care. Large Volume Bags, typically utilized for fluid administration in various healthcare settings, account for a significant share of usage due to their ability to provide continuous and extensive hydration or medication delivery, particularly in critical care and surgical environments. Conversely, Small Volume Bags are extensively utilized for precise medication dosing, catering to patients in various scenarios, from outpatient treatments to intensive care units.

    The preference for these bag types is influenced by factors such as increasing hospitalization rates and an expanding geriatric population, driving the demand for efficient and safe intravenous therapies. Moreover, ongoing advancements in bag technology and material safety are enhancing their acceptance among healthcare providers. Overall, the performance and growth of these bag types are integral to the India Intravenous Solution Market, influenced by continuous medical needs and evolving healthcare standards.

    Intravenous Solution Market Nutritional Content Insights

    The Nutritional Content segment within the India Intravenous Solution Market is gaining prominence as healthcare practitioners increasingly value the role of nutrition in patient recovery and overall health management. This segment encompasses various components, including Amino Acid Solutions, Carbohydrates, Vitamins Minerals, and Parenteral Lipid Emulsion, catering to diverse patient needs. Amino Acid Solutions are particularly significant as they play a crucial role in protein synthesis and ensuring proper metabolic function, making them indispensable for patients unable to consume food normally.Carbohydrates serve as a primary energy source, essential for maintaining energy levels in critically ill patients.

    Vitamins Minerals are integral for supporting bodily functions and bolstering metabolic pathways, while Parenteral Lipid Emulsion is important for providing essential fatty acids that support cell growth and overall health. The focus on tailored nutritional solutions supports the increasing need for quality healthcare in India's expanding population, thereby driving growth in this market segment. With advancements in formulations and a rising emphasis on nutritional therapy, the Nutritional Content segment is poised for significant advancements and innovations in the coming years.

    Intravenous Solution Market End User Insights

    The End User segment of the India Intravenous Solution Market plays a crucial role in the healthcare landscape, contributing significantly to the overall performance of the industry. Hospitals and clinics are among the primary users of intravenous solutions, providing essential treatments for patients, which is vital in emergency medicine and inpatient care.

    Ambulatory surgical centers have gained traction due to the increase in outpatient procedures, showcasing the rising demand for efficient intravenous therapy solutions in settings outside traditional hospitals.Home care is emerging as a vital segment, driven by the growing preference for at-home patient care, which offers convenience and cost-effective treatment options. This shift is complemented by the increasing adoption of advanced intravenous solutions that cater to personalized patient needs outside hospital environments. The rising prevalence of chronic diseases and advancements in medical technologies fuel growth in these areas, promoting better healthcare outcomes.

    Overall, the segmentation within the India Intravenous Solution Market reflects a robust growth trajectory, with hospitals, surgical centers, and home care playing pivotal roles in shaping the future of intravenous therapy in the region.The expanding healthcare infrastructure and an increasing focus on patient-centered care present substantial opportunities for further development in these segments.

    Get more detailed insights about India Intravenous Solution Market Research Report-Forecast to 2035

    Key Players and Competitive Insights

    The India Intravenous Solution Market is characterized by a robust competitive landscape driven by rising demand for safe and efficient intravenous therapies across various healthcare settings. This market is influenced by an increasing prevalence of chronic diseases and the critical need for effective hydration, nutrition, and medication administration in hospitalized patients. Companies operating in this space are focused on enhancing product quality, expanding their service portfolios, and leveraging technological advancements to improve patient outcomes. 

    The competitive dynamics are further shaped by factors such as regulatory compliance, pricing strategies, and the ability to forge strategic partnerships and collaborations within the healthcare ecosystem to capture a larger market share.B.Braun has established a significant presence within the India Intravenous Solution Market, which is recognized for its high-quality medical devices and solutions that cater to the diverse needs of healthcare providers and patients alike. The company has a strong emphasis on innovation and continuous improvement, which is reflected in its commitment to developing advanced intravenous therapies and infusion technology.

    B.Braun is renowned for its comprehensive product range, which includes intravenous fluids, delivery systems, and accessories critical for effective clinical application. The company's reputation for reliability, dedication to clinical support, and adherence to stringent quality standards further strengthen its competitive position in the market, positioning it as a trusted player among healthcare professionals.Vygon has carved a niche in the India Intravenous Solution Market through its specialized focus on medical devices primarily used for intravenous therapy. The company's strengths lie in its extensive product portfolio, which includes IV catheters, infusion sets, and associated devices designed to enhance patient safety and comfort.

    Vygon has been proactive in addressing the specific needs of the Indian healthcare system, leveraging its expertise in both manufacturing and innovation. The company maintains a competitive advantage through strategic collaborations and mergers that augment its market presence, thereby enhancing its distribution capabilities in India. Vygon’s commitment to quality and its investment in research and development ensure that it stays ahead in the competitive landscape, catering to the evolving needs of hospitals and healthcare facilities across the region.

    Key Companies in the India Intravenous Solution Market market include

    Industry Developments

    The India Intravenous Solution Market has seen significant developments recently, driven by an increasing demand for healthcare services, especially in critical care and surgical procedures. Major players such as B.Braun, Fresenius Kabi, and Dr. Reddy's Laboratories are expanding their offerings to include advanced IV solutions tailored for patient needs. In September 2023, Mylan announced a strategic collaboration with Sun Pharmaceutical Industries aimed at enhancing the supply of generic IV solutions across India. Additionally, Baxter Healthcare is investing in new manufacturing facilities to meet the growing demand for parenteral nutrition products.

    The market is projected to grow due to a rise in lifestyle diseases and an aging population. In recent years, companies like Hindustan Syringes and Medical Devices have shifted towards eco-friendly production methods, aligning with global sustainability goals. Notable mergers such as Medytox’s acquisition of a regional competitor in June 2023 further underscore the consolidation trend within the sector. The overall market has witnessed an upward trajectory, with a rising value predominantly influenced by policy reforms and increased spending on the healthcare infrastructure by the Indian government.

    Market Segmentation

    Outlook

    • Hospital Clinics
    • Ambulatory Surgical Centers
    • Home Care

    Intravenous Solution Market End User Outlook

    • Hospital Clinics
    • Ambulatory Surgical Centers
    • Home Care

    Intravenous Solution Market Nutrition Type Outlook

    • Total Parenteral Nutrition
    • Peripheral Parenteral Nutrition
    • Large Volume Bags (>250 ml)
    • Small Volume Bags (250 ml)

    Intravenous Solution Market Nutritional Content Outlook

    • Amino Acid Solution
    • Carbohydrates
    • Vitamins Minerals
    • Parenteral Lipid Emulsion

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 0.87(USD Billion)
    MARKET SIZE 2024 1.5(USD Billion)
    MARKET SIZE 2035 3.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.007% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED B.Braun, Vygon, Dr. Reddy's Laboratories, Mylan, Fresenius Kabi, Medytox, Baxter Healthcare, Amgen, Intravenous Solutions, Novartis, Sun Pharmaceutical Industries, Hindustan Syringes and Medical Devices, Terumo Corporation, Medtronic, C.R. Bard
    SEGMENTS COVERED Nutrition Type, Bag Type, Nutritional Content, End User
    KEY MARKET OPPORTUNITIES Growing demand for hydration therapies, Increasing prevalence of chronic diseases, Expansion of healthcare infrastructure, Rising geriatric population, Advancements in IV solution technology
    KEY MARKET DYNAMICS Rising demand for hydration therapy, Increasing prevalence of chronic diseases, Expanding healthcare infrastructure, Growing geriatric population, Technological advancements in IV solutions
    COUNTRIES COVERED India

    FAQs

    What is the expected market size of the India Intravenous Solution Market in 2024?

    The India Intravenous Solution Market is expected to be valued at 1.5 billion USD in 2024.

    What will be the market value of the India Intravenous Solution Market by 2035?

    By 2035, the India Intravenous Solution Market is projected to reach a value of 3.5 billion USD.

    What is the expected compound annual growth rate (CAGR) for the India Intravenous Solution Market from 2025 to 2035?

    The market is anticipated to grow at a CAGR of 8.007% from 2025 to 2035.

    Which segment of the India Intravenous Solution Market is expected to dominate in 2024?

    The Total Parenteral Nutrition segment is expected to be valued at 0.9 billion USD in 2024.

    How much is the Peripheral Parenteral Nutrition segment valued at in 2024?

    The Peripheral Parenteral Nutrition segment is projected to be valued at 0.6 billion USD in 2024.

    What is the expected market size for Total Parenteral Nutrition by 2035?

    Total Parenteral Nutrition is anticipated to grow to a valuation of 2.1 billion USD by 2035.

    What will be the market size of the Peripheral Parenteral Nutrition segment in 2035?

    By 2035, the Peripheral Parenteral Nutrition segment is expected to reach 1.4 billion USD.

    Who are the major players in the India Intravenous Solution Market?

    Key players include B.Braun, Vygon, Dr. Reddy's Laboratories, Mylan, and Fresenius Kabi.

    What are the key growth drivers for the India Intravenous Solution Market?

    Growth drivers include increasing healthcare needs, advancements in medical technology, and a rise in chronic diseases.

    How is the current market scenario impacting the growth of the India Intravenous Solution Market?

    The current global scenario is expected to create both challenges and opportunities affecting market expansion.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials